Corient Private Wealth LLC Has $1.28 Million Stake in Koninklijke Philips N.V. $PHG

Corient Private Wealth LLC lowered its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG) by 28.6% during the fourth quarter, HoldingsChannel reports. The firm owned 47,359 shares of the technology company’s stock after selling 19,000 shares during the quarter. Corient Private Wealth LLC’s holdings in Koninklijke Philips were worth $1,283,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Causeway Capital Management LLC raised its stake in shares of Koninklijke Philips by 5.8% in the 3rd quarter. Causeway Capital Management LLC now owns 1,958,112 shares of the technology company’s stock valued at $53,378,000 after purchasing an additional 107,117 shares during the period. M&T Bank Corp increased its stake in shares of Koninklijke Philips by 823.3% during the 4th quarter. M&T Bank Corp now owns 135,990 shares of the technology company’s stock worth $3,683,000 after purchasing an additional 121,261 shares during the last quarter. XY Capital Ltd raised its holdings in shares of Koninklijke Philips by 356.8% in the 3rd quarter. XY Capital Ltd now owns 64,413 shares of the technology company’s stock valued at $1,756,000 after purchasing an additional 50,313 shares during the period. Carmel Capital Partners LLC raised its holdings in shares of Koninklijke Philips by 58.0% in the 4th quarter. Carmel Capital Partners LLC now owns 115,627 shares of the technology company’s stock valued at $3,131,000 after purchasing an additional 42,446 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in Koninklijke Philips by 28.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 112,322 shares of the technology company’s stock valued at $3,062,000 after purchasing an additional 24,706 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

NYSE:PHG opened at $27.23 on Thursday. The company has a market cap of $26.76 billion, a price-to-earnings ratio of 23.33, a PEG ratio of 7.01 and a beta of 0.75. Koninklijke Philips N.V. has a fifty-two week low of $23.75 and a fifty-two week high of $33.44. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.90 and a current ratio of 1.32. The stock has a fifty day moving average price of $26.64 and a 200-day moving average price of $28.03.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Wednesday, May 6th. The technology company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.03. The company had revenue of $4.52 billion during the quarter, compared to the consensus estimate of $4.49 billion. Koninklijke Philips had a net margin of 5.49% and a return on equity of 13.51%. As a group, equities analysts anticipate that Koninklijke Philips N.V. will post 1.87 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHG has been the topic of a number of recent analyst reports. Weiss Ratings downgraded Koninklijke Philips from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, June 16th. Zacks Research cut Koninklijke Philips from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Finally, Wall Street Zen upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. (NYSE: PHG), commonly known as Philips, is a Dutch multinational company focused on health technology. Founded in Eindhoven in 1891, the company evolved from a diversified electronics manufacturer into a specialist in healthcare products, systems and services. Philips is legally registered in the Netherlands and operates globally, supplying equipment and solutions to hospitals, clinics, healthcare providers and consumers across Europe, the Americas and Asia.

Philips’ principal activities center on medical technologies and personal health.